Yossi Maimon, VP, Chief Financial Officer at Protalix BioTherapeutics, Inc. (PLX), sold 62,217 shares at $5.01 ($316K) on 2009-07-07, disclosed to the SEC on 2009-07-08.
Scheduled sale ($316k) by VP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.13 | 40,000 | $205K | 65.0% |
| 2 | $4.95 | 12,217 | $60K | 19.2% |
| 3 | $5.01 | 10,000 | $50K | 15.9% |
| Total | $5.08 avg | 62,217 | $316K | 100% |
| Filing → |
| PLX | SELL | 2010-10-08 | $677K | — | Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-10-19 | $1.4M | — | Filing → |